Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed A Hussain

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Seminars in Radiation Oncology|January 22, 2005
Management of muscle invasive bladder cancer--British approaches to organ conservationNicholas James, Syed A Hussain
Seminars in Radiation Oncology|January 22, 2005
Molecular markers in bladder cancerSyed A Hussain, Nicholas D James
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 3, 2009
Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy: a case-control studySyed A Hussain, Eric P Cohen
Kidney International|May 16, 2012
Chronic kidney disease in Pakistan: an under-recognized public health problemZeb I Saeed, Syed A Hussain
European Urology|July 31, 2019
Mutation Analysis of the FGFR3-encoding gene Does Not Predict Response to Checkpoint Inhibitor Treatment in Metastatic Bladder CancerNils O Elander, Syed A Hussain
The Lancet. Oncology|August 7, 2003
The systemic treatment of advanced and metastatic bladder cancerSyed A Hussain, Nicholas D James
Expert Review of Anticancer Therapy|December 31, 2002
Organ preservation strategies in bladder cancerSyed A Hussain, Nicholas D James
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
A multidisciplinary approach in muscle-invasive disease: novel chemotherapy combinations and targets in chemoradiationNicholas D James, Syed A Hussain
European Urology|October 5, 2020
Perioperative Treatment in Muscle-invasive Bladder Cancer: Analysis of Secondary Endpoints in a Randomized Trial Comparing Gemcitabine and Cisplatin Versus Dose-dense Methotrexate, Vinblastine, Adriamycin, and CisplatinIrbaz Bin Riaz, Syed A Hussain
Oncology (Williston Park, N.Y.)|May 19, 2016
PARP Inhibition in Prostate Cancer: A Promising ApproachNils O Elander, Syed A Hussain
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Seminars in Radiation Oncology|January 22, 2005
Management of muscle invasive bladder cancer--British approaches to organ conservationNicholas James, Syed A Hussain
Seminars in Radiation Oncology|January 22, 2005
Molecular markers in bladder cancerSyed A Hussain, Nicholas D James
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 3, 2009
Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy: a case-control studySyed A Hussain, Eric P Cohen
Kidney International|May 16, 2012
Chronic kidney disease in Pakistan: an under-recognized public health problemZeb I Saeed, Syed A Hussain
European Urology|July 31, 2019
Mutation Analysis of the FGFR3-encoding gene Does Not Predict Response to Checkpoint Inhibitor Treatment in Metastatic Bladder CancerNils O Elander, Syed A Hussain
The Lancet. Oncology|August 7, 2003
The systemic treatment of advanced and metastatic bladder cancerSyed A Hussain, Nicholas D James
Expert Review of Anticancer Therapy|December 31, 2002
Organ preservation strategies in bladder cancerSyed A Hussain, Nicholas D James
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
A multidisciplinary approach in muscle-invasive disease: novel chemotherapy combinations and targets in chemoradiationNicholas D James, Syed A Hussain
European Urology|October 5, 2020
Perioperative Treatment in Muscle-invasive Bladder Cancer: Analysis of Secondary Endpoints in a Randomized Trial Comparing Gemcitabine and Cisplatin Versus Dose-dense Methotrexate, Vinblastine, Adriamycin, and CisplatinIrbaz Bin Riaz, Syed A Hussain
Oncology (Williston Park, N.Y.)|May 19, 2016
PARP Inhibition in Prostate Cancer: A Promising ApproachNils O Elander, Syed A Hussain
Pageof 15